Ligand validation:6T6N

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6T6N_GOL_B_301	62%	74%	0.15	0.941	0.51	0.49	-	-	0	0	100%	1
6T6N_GOL_C_301	51%	92%	0.192	0.948	0.15	0.37	-	-	0	0	100%	1
6T6N_GOL_H_301	44%	79%	0.186	0.915	0.5	0.36	-	-	1	0	100%	1
6T6N_GOL_H_302	40%	67%	0.218	0.929	0.31	0.95	-	-	0	0	100%	1
6T6N_GOL_G_302	40%	84%	0.228	0.939	0.38	0.39	-	-	0	0	100%	1
6T6N_GOL_C_302	36%	76%	0.251	0.946	0.3	0.63	-	-	0	0	100%	1
6T6N_GOL_D_301	36%	82%	0.199	0.891	0.3	0.5	-	-	0	0	100%	1
6T6N_GOL_G_304	35%	86%	0.214	0.905	0.34	0.37	-	-	0	0	100%	1
6T6N_GOL_F_301	34%	73%	0.256	0.943	0.39	0.66	-	-	0	0	100%	1
6T6N_GOL_D_302	33%	54%	0.252	0.931	0.61	1.15	-	1	1	0	100%	1
6T6N_GOL_D_303	30%	81%	0.228	0.891	0.32	0.49	-	-	0	0	100%	1
6T6N_GOL_E_301	21%	73%	0.305	0.915	0.38	0.67	-	-	0	0	100%	1
6T6N_GOL_B_302	20%	81%	0.218	0.818	0.46	0.36	-	-	0	0	100%	1
6T6N_GOL_G_303	19%	69%	0.217	0.809	0.67	0.52	-	-	0	0	100%	1
6T6N_GOL_A_301	16%	62%	0.351	0.922	0.58	0.87	-	-	0	0	100%	1
6T6N_GOL_G_301	15%	72%	0.373	0.941	0.27	0.78	-	-	1	0	100%	1
6T6N_GOL_C_303	13%	90%	0.313	0.861	0.28	0.31	-	-	0	0	100%	1
6T6N_GOL_E_302	10%	83%	0.419	0.933	0.29	0.49	-	-	0	0	100%	1
6T6N_GOL_F_302	0%	75%	0.729	0.754	0.57	0.41	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.